People: Fitbit Inc (FIT.N)

FIT.N on New York Stock Exchange

17 Sep 2019
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Fluegel, Bradley 

Mr. Bradley M. Fluegel is an Independent Director of Fitbit, Inc. Mr. Fluegel has served as a member of our board of directors since March 2018. Mr. Fluegel served as Senior Vice President, Chief Healthcare Commercial Market Development Officer of Walgreen Co., a retail-pharmacy store chain, from October 2015 to January 2018. Mr. Fluegel joined Walgreen in October 2012 as Senior Vice President, Chief Strategy and Business Development Officer after previously serving as Executive in Residence at Health Evolution Partners, a healthcare private equity firm, from April 2011 to September 2012. Prior to joining Health Evolution Partners, Mr. Fluegel served as Executive Vice President and Chief Strategy and External Affairs Officer of Wellpoint, Inc. (now Anthem, Inc.), a health care benefits company, from September 2007 to December 2010. Prior to that, Mr. Fluegel served as Senior Vice President of National Accounts and Vice President, Enterprise Strategy at Aetna Inc., a health care benefits company, from 2005 to 2007. Prior to this, Mr. Fluegel served as Chief Executive Officer for Reden & Anders, Ltd. (now part of Optum), a provider of consulting services for the health care industry, from 2002 to 2005, and served in various positions at Tillinghast-Towers Perrin, a clinical, actuarial and management consulting practice serving the health care industry, from 1995 to 2002. Mr. Fluegel holds a B.A. in business administration from the University of Washington and a Masters in Public Policy from Harvard University. Mr. Fluegel currently serves on the board of directors of Performant Financial Corporation and has also served on the board of directors for a number of private companies. He also is a lecturer at the University of Pennsylvania’s Wharton School of Business. Mr. Fluegel was selected to serve as a member of our board of directors due to his extensive commercial healthcare industry and operational experience.

Basic Compensation

Total Annual Compensation, USD 72,111
Restricted Stock Award, USD 216,647
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 288,758

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Park


Ronald Kisling


Andrew Missan


Jeffrey Devine


Eric Friedman


Steven Murray

As Of  31 Dec 2018